UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000056769
Receipt number R000064886
Scientific Title Research on the effects of protein and kestose intake on the intestinal environment
Date of disclosure of the study information 2025/01/21
Last modified on 2025/01/21 12:21:30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Research on the effects of protein and kestose intake on the intestinal environment

Acronym

Research on the effects of protein and kestose intake on the intestinal environment

Scientific Title

Research on the effects of protein and kestose intake on the intestinal environment

Scientific Title:Acronym

Research on the effects of protein and kestose intake on the intestinal environment

Region

Japan


Condition

Condition

Healthy Adults

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effect on the intestinal environment of adult men and women aged 20 years or older when they take a kestose-containing protein for four weeks.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Intestinal flora

Key secondary outcomes

Intestinal bacteria count
Concentration of short-chain fatty acids in feces
Defecation habits questionnaire
Dietary survey (BDHQ)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Take 30g of kestose-containing protein with water every day for four weeks, at any time.

Interventions/Control_2

Take 30g of maltose-containing protein with water every day for four weeks, at any time.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document
2.Healthy Japanese men and women aged 20 years or older

Key exclusion criteria

1.Persons who have chronic illness, receiving medication, have a serious disease history
2.Persons who are allergic to the test food
3.Persons who usually take a large amount of kestose or protein
4.Persons who regularly take or wish to take during the study period medicines (antibiotics, bifidobacteria preparations, etc.), health functional foods (foods for specified health uses, foods with functional claims, and foods with nutrient functions), foods with prebiotic effects (foods with high dietary fiber and oligosaccharide content), and foods with probiotic effects (yogurt containing bifidobacteria, etc.) that may affect the intestinal environment
5.Defecation frequency less than 2 times/week
6.Persons who have participated in other tests within the first month before the start of the test, or those who intend to participate in another exam after consenting to this exam
7.Persons who were judged as inappropriate for study participants by the principal investigator
8.Persons who are pregnant, planning or hoping to be pregnant during the study period, breastfeeding

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Takamasa
Middle name
Last name Masuda

Organization

Healthcare Systems Co., Ltd.

Division name

Clinical Research Department

Zip code

105-0004

Address

Park Place Bld. 5F, 5-27-1, Shinbashi, Minato-ku, Tokyo, JAPAN

TEL

03-6809-2722

Email

masudat@hc-sys.jp


Public contact

Name of contact person

1st name Takamasa
Middle name
Last name Masuda

Organization

Healthcare Systems Co., Ltd.

Division name

Clinical Research Department

Zip code

105-0004

Address

Park Place Bld. 5F, 5-27-1, Shinbashi, Minato-ku, Tokyo, JAPAN

TEL

03-6809-2722

Homepage URL


Email

masudat@hc-sys.jp


Sponsor or person

Institute

Healthcare Systems Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Bussan Food Science Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Ethics Committee of Healthcare Systems Co., Ltd.

Address

1-14-18, Shirakane, Showa-ku, Nagoya, Aichi, JAPAN

Tel

03-6809-2722

Email

soumu@hc-sys.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 01 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 12 Month 27 Day

Date of IRB

2024 Year 12 Month 27 Day

Anticipated trial start date

2025 Year 01 Month 24 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 01 Month 21 Day

Last modified on

2025 Year 01 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064886